A detailed history of Signaturefd, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Signaturefd, LLC holds 365 shares of IONS stock, worth $12,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
365
Previous 340 7.35%
Holding current value
$12,705
Previous $16,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$40.06 - $51.86 $1,001 - $1,296
25 Added 7.35%
365 $14,000
Q2 2024

Jul 29, 2024

SELL
$36.45 - $47.7 $546 - $715
-15 Reduced 4.23%
340 $16,000
Q1 2024

May 03, 2024

SELL
$42.03 - $53.55 $6,136 - $7,818
-146 Reduced 29.14%
355 $15,000
Q4 2023

Jan 31, 2024

BUY
$43.39 - $51.63 $5,857 - $6,970
135 Added 36.89%
501 $25,000
Q3 2023

Nov 03, 2023

SELL
$38.5 - $47.13 $4,235 - $5,184
-110 Reduced 23.11%
366 $16,000
Q2 2023

Aug 01, 2023

BUY
$34.73 - $43.33 $8,821 - $11,005
254 Added 114.41%
476 $19,000
Q1 2023

Apr 28, 2023

SELL
$33.58 - $41.2 $302 - $370
-9 Reduced 3.9%
222 $7,000
Q4 2022

Jan 27, 2023

SELL
$37.12 - $46.52 $631 - $790
-17 Reduced 6.85%
231 $8,000
Q3 2022

Nov 08, 2022

BUY
$36.54 - $48.66 $219 - $291
6 Added 2.48%
248 $11,000
Q2 2022

Aug 10, 2022

SELL
$31.71 - $43.0 $9,481 - $12,857
-299 Reduced 55.27%
242 $9,000
Q1 2022

May 02, 2022

SELL
$29.88 - $37.04 $4,033 - $5,000
-135 Reduced 19.97%
541 $20,000
Q4 2021

Jan 25, 2022

SELL
$25.61 - $35.1 $5,378 - $7,371
-210 Reduced 23.7%
676 $21,000
Q3 2021

Oct 28, 2021

SELL
$33.54 - $40.55 $2,917 - $3,527
-87 Reduced 8.94%
886 $30,000
Q2 2021

Jul 26, 2021

BUY
$34.54 - $47.25 $6,700 - $9,166
194 Added 24.9%
973 $39,000
Q1 2021

Apr 30, 2021

BUY
$42.51 - $63.78 $6,546 - $9,822
154 Added 24.64%
779 $35,000
Q4 2020

Feb 11, 2021

SELL
$45.3 - $60.27 $1,494 - $1,988
-33 Reduced 5.02%
625 $35,000
Q3 2020

Nov 03, 2020

BUY
$47.45 - $62.95 $2,040 - $2,706
43 Added 6.99%
658 $31,000
Q2 2020

Jul 30, 2020

SELL
$46.85 - $61.05 $1,780 - $2,319
-38 Reduced 5.82%
615 $36,000
Q1 2020

Apr 23, 2020

BUY
$41.6 - $63.4 $1,830 - $2,789
44 Added 7.22%
653 $31,000
Q4 2019

Feb 05, 2020

SELL
$53.85 - $65.27 $3,446 - $4,177
-64 Reduced 9.51%
609 $37,000
Q2 2019

Jul 31, 2019

BUY
$62.09 - $86.14 $2,173 - $3,014
35 Added 5.49%
673 $43,000
Q1 2019

May 09, 2019

SELL
$52.92 - $81.17 $899 - $1,379
-17 Reduced 2.6%
638 $52,000
Q4 2018

Feb 13, 2019

SELL
$43.37 - $59.54 $1,040 - $1,428
-24 Reduced 3.53%
655 $35,000
Q3 2018

Nov 15, 2018

SELL
$42.88 - $53.7 $1,286 - $1,611
-30 Reduced 4.23%
679 $35,000
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $16,374 - $20,482
404 Added 132.46%
709 $30,000
Q1 2018

May 08, 2018

BUY
$44.08 - $55.05 $13,444 - $16,790
305 New
305 $13,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.94B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.